Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients

American Journal of Hypertension

Volumn 11, Issue 9, 1998, Pages 1093-1099

  Poulsen, Per Løgstrup ^a   Ebbehoj E ^a   Hansen, Klavs W ^a   Mogensen, Carl Erik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

24 h ambulatory blood pressure; Autonomic function; Insulin dependent diabetes mellitus; Power spectral analysis; Smoking; Urinary albumin excretion

Indexed keywords

INSULIN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MONITORING; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SMOKING;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING;

EID: 0032167441     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00115-0     Document Type: Article

References (50)

1. 1. Wilhelmsen L: Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988;115:242-249.
2. 2. Gordon T, Kannel WB, Dawber TR, McGee D: Changes associated with quitting cigarette smoking: the Framingham study. Am Heart J 1975;90:322-328.
3. 3. Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 1987;294:1651-1654.
4. 4. Christiansen JS: Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1978;1:146-149.
5. 5. Telmer S, Christiansen JS, Andersen AR, et al: Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984;215:63-68.
6. 6. Norden G, Nyberg G: Smoking and diabetic nephropathy. Acta Med Scand 1984;215:257-261.
7. 7. Muhlhauser I, Sawicki P, Berger M: Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 1986;29:500-502.
8. 8. Chase HP, Garg SK, Marshall G, et al: Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 1991;265:614-617.
9. 9. Ekberg G, Grefberg N, Larsson LO: Cigarette smoking and urinary albumin excretion in insulin-treated diabetics without manifest nephropathy. J Intern Med 1991;230:435-442.
10. 10. Microalbuminuria Collaborative Study Group United Kingdom: Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993;306:1235-1239.
11. 11. Sawicki PT, Muhlhauser I, Bender R, et al: Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy. J Intern Med 1996;239:345-352.
12. 12. Sawicki PT, Didjurgeit U, Muhlhauser I, et al: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994;17:126-131.
13. 13. Stegmayr BG: A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death. J Intern Med 1990;228:121-124.
14. 14. Kannel WB: Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275:1571-1576.
15. 15. Poulsen PL, Hansen KW, Mogensen CE: Ambulatory blood pressure in the transition from normo-to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 1994;43:1248-1253.
16. 16. Mathiesen ER, Ronn B, Storm B, et al: The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995;12: 482-487.
17. 17. Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993;42:715-719.
18. 18. Cryer PE, Haymond MW, Santiago JV, Shah SD: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
19. 19. Niedermaier ON, Smith ML, Beightol LA, et al: Influence of cigarette smoking on human autonomic function. Circulation 1993;88:562-571.
20. 20. Hansen HP, Rossing K, Jacobsen P, et al: The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria. Scand J Clin Lab Invest 1996;56:393-399.
21. 21. Seltzer CC: Effect of smoking on blood pressure. Am Heart J 1974;87:558-564.
22. 22. Green MS, Jucha E, Luz Y: Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 1986;111:932-940.
23. 23. Karvonen M, Keys A, Orma E, et al: Cigarette smoking, serum-cholesterol, blood-pressure, and body fatness. Observations in Finland. Lancet 1956;i:492-494.
24. 24. Higgins MW, Kjelsberg M: Characteristics of smokers and nonsmokers in Tecumseh, Michigan. II. The distribution of selected physical measurements and physiologic variables and the prevalence of certain diseases in smokers and nonsmokers. Am J Epidemiol 1967;86:60-77.
25. 25. Berglund G, Wilhelmsen L: Factors related to blood pressure in a general population sample of Swedish men. Acta Med Scand 1975;198:291-298.
26. 26. Hansen KW, Pedersen MM, Christiansen JS, Mogensen CE: Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. Blood Press 1994;3:381-388.
27. 27. Mikkelsen KL, Wiinberg N, Hcegholm A, et al: Smoking related to 24-h ambulatory blood pressure and heart rate. A study in 352 normotensive Danish subjects. Am J Hypertens 1997;10:483-491.
28. 28. Green MS, Harari G, Schwartz K: Cigarette smoking related to ambulatory blood pressure and heart rate. Am Heart J 1991;121:1569-1570.
29. 29. Bodmer CW, Valentine DT, Masson EA, et al: Smoking attenuates the vasoconstrictor response to noradrenaline in type I diabetic patients and normal subjects: possible relevance to diabetic nephropathy. Eur J Clin Invest 1994;24:331-336.
30. 30. Bernardi L, Ricordi L, Lazzari P, et al: Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 1992;86:1443-1452.
31. 31. Molgaard H, Christensen PD, Sorensen KE, et al: Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992;41:812-817.
32. 32. Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE: 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 1997;40:718-725.
33. 33. Klein R, Klein BE, Moss SE, et al: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-526.
34. 34. O'Brien E, Mee F, Atkins N, O'Malley K: Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens 1991;9:573-574.
35. 35. Akselrod S, Gordon D, Ubel FA, et al: Power spectrum analysis of the heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-222.
36. 36. Pomeranz B, Macaulay RJ, Caudill MA, et al: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
37. 37. Furlan R, Guzzetti S, Crivellaro W, et al: Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537-547.
38. 38. Ewing DJ, Neilson JM, Shapiro CM, et al: Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 1991;65:239-244.
39. 39. Malpas SC, Maling TJB: Heart-rate variability and cardiac autonomic function in diabetes. Diabetes 1990;39: 1177-1181.
40. 40. Hayano J, Sakakibara Y, Yamada A, et al: Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991;67:199-204.
41. 41. Sallinger J, Vychodil R, Pumprla J, et al: Telemetric computer-aided system for non-invasive examination of heart rate variability, type VariaPulse TF3. Comput Cardiol 1995; IEEE Proc:437-440.
42. 41. Sallinger J, Vychodil R, Pumprla J, et al: Telemetric computer-aided system for non-invasive examination of heart rate variability, type VariaPulse TF3. Comput Cardiol 1995; IEEE Proc:437-440.
43. 42. Yamamoto Y, Hughson RL: Coarse-graining spectral analysis: new method for studying heart rate variability. J Appl Physiol 1991;71:1143-1150.
44. 43. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-498.
45. 44. Sinha RN, Patrick AW, Richardson L, MacFarlane IA: Diurnal variation in blood pressure in insulin-dependent diabetic smokers and non-smokers with and without microalbuminuria. Diabet Med 1997;14:291-295.
46. 45. Benowitz NL, Sharp DS: Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation 1989;80:1309-1312.
47. 46. Steiner G: Diabetes and atherosclerosis: an overview. Diabetes 1981;30:1-7.
48. 47. Oxlund H, Rasmussen LM, Andreassen TT, Heickendorff L: Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989;32:748-752.
49. 48. Thordarson H, Thorgeirsson G, Helgason T: Aortic stiffness in insulin-dependent diabetics: an echocardiographic study. Diabet Med 1986;3:449-454.
50. 49. Hayano J, Yamada M, Sakakibara Y, et al: Short-and long-term effects of cigarette smoking on heart rate variability. Am J Cardiol 1990;65:84-88.-